Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-11

FDA Approved: NITAZOXANIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for nitazoxanide submitted by Rising Pharma Holdings, Inc. (Nitazoxanide).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitazoxanide (nitazoxanide)

Snippet

SUPPL AP for NITAZOXANIDE (NITAZOXANIDE)